Catalyst Wire Dossier Catalyst Wire Dossier

KAF156 (ganaplacide)

ganaplacide · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KAF156 (ganaplacide), covering 2024-09-25 to 2024-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

See pricing